Skip to content

Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea

Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04422587
Acronym
EPRICOD
Enrollment
1860
Registered
2020-06-09
Start date
2020-03-13
Completion date
2020-06-07
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergencies

Keywords

COVID-19, diagnostic strategy, acute dyspnea

Brief summary

This research aims to improve our knowledge of the epidemiology of patients consulting in the COvid-19 Possible REspiratory Units (RECOP unit). Indeed, the epidemic linked to COVID-19 affects France and impacts its health system. The reception of all intermediate patients will be on the Emergency Structures (SU). Indeed, the French healthcare system centralizes unscheduled urgent care on the ER. The aspecific respiratory symptomatology in intermediate patients indicates them all the more at an admission to SU or the diagnostic approach to respiratory difficulty may be carried out. A central issue of this diagnostic strategy will be to be rapid, since the diagnosis will have to be made in the context of significant flows, with a need to quickly refer patients to the most suitable downstream service, while limiting the risk contamination of caregivers and vulnerable patients if a COVID-19 + patient is admitted to an unsuitable service. However, virological tests do not currently allow rapid results for COVID-19. Research project of investigatory aims to develop a predictive model of the risk of being COVID-19 positive for patients admitted to the emergency room for acute dyspnea.

Interventions

All patients admit in RECOP unit for dyspnea can be included in this study if patient is agree. Then, doctor collects demographic variables, the usual history and treatments, the characteristics of the episode (symptomatology, evolution, treatment taken) and the data from the initial clinical examination will be identified.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients over 15 years admitted to the RECOP unit for dyspnea

Exclusion criteria

* Patient admitted to shock for respiratory distress requiring immediate respiratory support. * Patient under justice safeguard

Design outcomes

Primary

MeasureTime frameDescription
Develop a predictive model of the risk of being COVID-19 for patients admitted to the emergency room for dyspneainclusion daydemographic variables, usual history and treatments, episode characteristics (symptomatology, evolution, treatment taken) and data from the initial clinical examination will be collected by doctor

Secondary

MeasureTime frameDescription
Describe the characteristics of patients admitted to reCOP units according to their virological status30 daysThe COVID-19 virological condition will be taken with PCR tests on naso-pharyngeal samples or on sputum for patients taking
Virological status30 daysVirological status will be collected by a phone call at the patient
Mortality status30 daysMortality status will be collected by a phone call at the patient

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026